Q&A: Development Scientist at AGC Biologics Sara Morlacchi analyzes the growth of the cell therapy industry and barriers for cost and accessibility.
The Next Frontier: Industrializing Cell Therapy Manufacturing Read More »
With three FDA approvals in the past 10 months, there is a lot of momentum in the Duchenne muscular dystrophy space. Here are five companies looking to keep it going.
Ketabon is working to develop a medication that harnesses ketamine’s antidepressant effects without the safety issues that currently prohibit its at-home use.
FDA Commissioner Robert Califf has said that advisory committee meetings should focus more on discussion and be “less about the outcome,” but other agency officials recently advocated for retaining the vote on whether to approve a product under review.
Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format Read More »
Jeffrey Chamberlain, president of the American Society of Gene & Cell Therapy, spoke with BioSpace about what we can expect to learn about in Baltimore this week.
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector Read More »
According to recent study by nova one advisor, the U.S. cell separation market size was valued at USD 3.90 billion in 2023 and is anticipated to reach around USD 8.27 billion by the end of 2033, representing an impressive CAGR of 7.8% from 2024 to 2033.
U.S. Cell Separation Market is Rising Rapidly Up to USD 8.27 Bn by 2033 Read More »
Esta es la reconstrucción facial aproximada del rostro que probablemente tuvo una mujer neandertal que vivió hace 75.000 años en lo que hoy es el Kurdistán iraquí. La reconstrucción facial es obra de los hermanos Kennis. Los restos fósiles de …
Reconstruyen el rostro que tuvo en vida una mujer neandertal de hace 75.000 años Read More »
El meningomielocele, una de las formas más severas y frecuentes de espina bífida, es un tipo grave de defecto del tubo neural que a menudo requiere reparación quirúrgica prenatal o posnatal y puede dar lugar a diversas dificultades físicas y de desarrollo. …
Alteración cromosómica que aumenta el riesgo de espina bífida grave Read More »
Under the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and connect them with a Phase III clinical trial for Boehringer’s GLP-1 drug survodutide.
Walgreens inks GLP-1 clinical trial deal with major German drugmaker Read More »
La investigación que lo revela también abre la puerta al desarrollo de drones más sofisticados. Los drones actuales (aeronaves autónomas muy útiles con diversos campos de aplicación) aún no logran emular los sofisticados sistemas biomec&aacut …
Averiguan cómo comenzaron a volar los murciélagos Read More »
